Kambiz Rahbar | IKIM MMLhttps://mml.kite.ume.de/authors/kambiz-rahbar/Kambiz RahbarHugoBlox Kit (https://hugoblox.com)en-usFri, 01 May 2026 00:00:00 +0000Salvage Radiotherapy Confers an Overall Survival Advantage in Biochemical Recurrence of Prostate Cancer: Evidence from the International PROMISE Registryhttps://mml.kite.ume.de/publications/guberina-salvage-2026/Fri, 01 May 2026 00:00:00 +0000https://mml.kite.ume.de/publications/guberina-salvage-2026/Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer: a multicentre retrospective studyhttps://mml.kite.ume.de/publications/karpinski-combining-2024/Sun, 01 Sep 2024 00:00:00 +0000https://mml.kite.ume.de/publications/karpinski-combining-2024/PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [177Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysishttps://mml.kite.ume.de/publications/seifert-psma-2020/Tue, 01 Sep 2020 00:00:00 +0000https://mml.kite.ume.de/publications/seifert-psma-2020/Semi-automatically quantified tumor volume using Ga-68-PSMA-11-PET as biomarker for survival in patients with advanced prostate cancerhttps://mml.kite.ume.de/publications/seifert-semi-automatically-2020/Wed, 01 Apr 2020 00:00:00 +0000https://mml.kite.ume.de/publications/seifert-semi-automatically-2020/Analysis of PSMA expression and outcome in patients with advanced Prostate Cancer receiving $^textrm177$ Lu-PSMA-617 Radioligand Therapyhttps://mml.kite.ume.de/publications/seifert-analysis-2020/Wed, 01 Jan 2020 00:00:00 +0000https://mml.kite.ume.de/publications/seifert-analysis-2020/